Connection

Perry Molinoff to Rats

Back to Details
This is a "connection" page, showing publications Perry Molinoff has written about Rats.
Perry Molinoff
Connection Strength
0.897
Rats
  1. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci U S A. 2004 Jul 06; 101(27):10201-4.
    View in: PubMed
    Score: 0.033
  2. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102.
    View in: PubMed
    Score: 0.030
  3. Characterization of 5-HT- and ionomycin-stimulated changes in levels of intracellular calcium and PI hydrolysis in P11 cells. Ann N Y Acad Sci. 1998 Dec 15; 861:240-1.
    View in: PubMed
    Score: 0.022
  4. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. Mol Pharmacol. 1996 Sep; 50(3):631-8.
    View in: PubMed
    Score: 0.019
  5. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells. J Pharmacol Exp Ther. 1996 Feb; 276(2):784-94.
    View in: PubMed
    Score: 0.018
  6. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem. 1995 Feb; 64(2):531-9.
    View in: PubMed
    Score: 0.017
  7. Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J Biol Chem. 1994 Dec 16; 269(50):31850-7.
    View in: PubMed
    Score: 0.017
  8. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb; 268(2):935-42.
    View in: PubMed
    Score: 0.016
  9. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.
    View in: PubMed
    Score: 0.015
  10. Development of polyclonal anti-D2 dopamine receptor antibodies to fusion proteins: inhibition of D2 receptor-G protein interaction. J Neurochem. 1993 Jun; 60(6):2181-91.
    View in: PubMed
    Score: 0.015
  11. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells. Mol Pharmacol. 1993 May; 43(5):726-33.
    View in: PubMed
    Score: 0.015
  12. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993 May; 43(5):666-76.
    View in: PubMed
    Score: 0.015
  13. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993 Feb; 264(2):1002-11.
    View in: PubMed
    Score: 0.015
  14. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron. 1993 Feb; 10(2):267-78.
    View in: PubMed
    Score: 0.015
  15. An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site. J Pharmacol Exp Ther. 1992 Aug; 262(2):539-44.
    View in: PubMed
    Score: 0.014
  16. Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat. Brain Res. 1992 Jul 03; 584(1-2):45-54.
    View in: PubMed
    Score: 0.014
  17. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol Pharmacol. 1992 Jul; 42(1):147-51.
    View in: PubMed
    Score: 0.014
  18. Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers. J Neurochem. 1992 Apr; 58(4):1300-7.
    View in: PubMed
    Score: 0.014
  19. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site. Mol Pharmacol. 1992 Apr; 41(4):785-92.
    View in: PubMed
    Score: 0.014
  20. Quantitation of isotypes of D2 receptors using solution hybridization. Neurochem Int. 1992 Mar; 20 Suppl:189S-195S.
    View in: PubMed
    Score: 0.014
  21. Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. Mol Pharmacol. 1991 Nov; 40(5):774-82.
    View in: PubMed
    Score: 0.014
  22. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation. J Pharmacol Exp Ther. 1991 Oct; 259(1):337-44.
    View in: PubMed
    Score: 0.013
  23. Polyamines modulate the binding of [3H]MK-801 to the solubilized N-methyl-D-aspartate receptor. J Neurochem. 1991 Sep; 57(3):811-8.
    View in: PubMed
    Score: 0.013
  24. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol Pharmacol. 1991 Apr; 39(4):531-9.
    View in: PubMed
    Score: 0.013
  25. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron. 1990 Aug; 5(2):199-208.
    View in: PubMed
    Score: 0.012
  26. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol Pharmacol. 1990 May; 37(5):622-30.
    View in: PubMed
    Score: 0.012
  27. Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol. 1989 Oct; 36(4):575-81.
    View in: PubMed
    Score: 0.012
  28. Subtype-selective immunoprecipitation of the beta 2-adrenergic receptor. J Neurochem. 1989 Aug; 53(2):362-9.
    View in: PubMed
    Score: 0.012
  29. Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine. J Neurosci. 1989 Jul; 9(7):2297-305.
    View in: PubMed
    Score: 0.012
  30. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 1989; 3(1):74-82.
    View in: PubMed
    Score: 0.011
  31. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther. 1988 Mar; 244(3):987-93.
    View in: PubMed
    Score: 0.010
  32. Endogenous modulators of binding of [3H]nitrendipine in extracts of rat brain. J Pharmacol Exp Ther. 1988 Mar; 244(3):971-6.
    View in: PubMed
    Score: 0.010
  33. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland. J Pharmacol Exp Ther. 1987 Sep; 242(3):950-6.
    View in: PubMed
    Score: 0.010
  34. Interactions of beta-adrenergic receptors with a membrane protein other than the stimulatory guanine nucleotide-binding protein. Biochem Pharmacol. 1987 Jul 15; 36(14):2263-9.
    View in: PubMed
    Score: 0.010
  35. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986 Nov; 6(11):3177-88.
    View in: PubMed
    Score: 0.010
  36. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37.
    View in: PubMed
    Score: 0.010
  37. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23.
    View in: PubMed
    Score: 0.010
  38. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol. 1986 Aug; 30(2):104-11.
    View in: PubMed
    Score: 0.009
  39. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol. 1986 Apr 25; 57(12):17F-22F.
    View in: PubMed
    Score: 0.009
  40. Adenylate kinase increases adenylate cyclase activity in membranes from rat lung. J Cyclic Nucleotide Protein Phosphor Res. 1986; 11(1):63-73.
    View in: PubMed
    Score: 0.009
  41. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther. 1985 Dec; 235(3):657-64.
    View in: PubMed
    Score: 0.009
  42. Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortex. Alcohol Drug Res. 1985-1986; 6(6):379-86.
    View in: PubMed
    Score: 0.008
  43. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61.
    View in: PubMed
    Score: 0.008
  44. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. J Pharmacol Exp Ther. 1984 Sep; 230(3):614-8.
    View in: PubMed
    Score: 0.008
  45. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Mol Pharmacol. 1983 Nov; 24(3):398-408.
    View in: PubMed
    Score: 0.008
  46. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Mol Pharmacol. 1983 Mar; 23(2):303-9.
    View in: PubMed
    Score: 0.007
  47. Effects of drugs on beta-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol. 1983; 5 Suppl 1:S63-7.
    View in: PubMed
    Score: 0.007
  48. beta-Adrenergic receptor subtypes in rat brain. Adv Biochem Psychopharmacol. 1983; 36:73-81.
    View in: PubMed
    Score: 0.007
  49. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Res. 1982 Dec 09; 252(2):309-14.
    View in: PubMed
    Score: 0.007
  50. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7561-5.
    View in: PubMed
    Score: 0.007
  51. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther. 1982 May; 221(2):439-43.
    View in: PubMed
    Score: 0.007
  52. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Res. 1982 Feb 25; 234(2):474-9.
    View in: PubMed
    Score: 0.007
  53. Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors. J Biol Chem. 1982 Jan 25; 257(2):804-10.
    View in: PubMed
    Score: 0.007
  54. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res. 1981 May 04; 211(2):315-27.
    View in: PubMed
    Score: 0.007
  55. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation. Mol Pharmacol. 1981 May; 19(3):372-8.
    View in: PubMed
    Score: 0.007
  56. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7.
    View in: PubMed
    Score: 0.006
  57. Selective survival of beta 1-adenergic receptors in rat cerebellum following neonatal x-irradiation. Brain Res. 1981 Mar 23; 209(1):25-34.
    View in: PubMed
    Score: 0.006
  58. Effects of hypoxia on density of beta-adrenergic receptors. J Appl Physiol Respir Environ Exerc Physiol. 1981 Feb; 50(2):363-6.
    View in: PubMed
    Score: 0.006
  59. Interactions of agonists and antagonists with beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14:51-67.
    View in: PubMed
    Score: 0.006
  60. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Mol Pharmacol. 1980 Nov; 18(3):341-7.
    View in: PubMed
    Score: 0.006
  61. Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. J Neurochem. 1980 Jul; 35(1):273-5.
    View in: PubMed
    Score: 0.006
  62. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res. 1980 Apr 28; 188(2):357-68.
    View in: PubMed
    Score: 0.006
  63. Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues. J Cyclic Nucleotide Res. 1980; 6(3):217-30.
    View in: PubMed
    Score: 0.006
  64. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Mol Pharmacol. 1980 Jan; 17(1):1-7.
    View in: PubMed
    Score: 0.006
  65. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration. Brain Res. 1979 Dec 14; 178(2-3):589-95.
    View in: PubMed
    Score: 0.006
  66. Comparison of beta adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Ther. 1979 Dec; 211(3):502-8.
    View in: PubMed
    Score: 0.006
  67. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. J Pharmacol Exp Ther. 1979 Sep; 210(3):433-9.
    View in: PubMed
    Score: 0.006
  68. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. J Pharmacol Exp Ther. 1979 Aug; 210(2):215-21.
    View in: PubMed
    Score: 0.006
  69. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul; 16(1):21-33.
    View in: PubMed
    Score: 0.006
  70. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46.
    View in: PubMed
    Score: 0.006
  71. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science. 1979 May 25; 204(4395):866-8.
    View in: PubMed
    Score: 0.006
  72. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov; 207(2):446-57.
    View in: PubMed
    Score: 0.005
  73. Effect of guanine nucleotides on striatal dopamine receptors. Nature. 1978 Oct 05; 275(5679):453-5.
    View in: PubMed
    Score: 0.005
  74. Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosed dopamine beta-hydroxylase. J Pharmacol Exp Ther. 1978 May; 205(2):357-65.
    View in: PubMed
    Score: 0.005
  75. Regulation of beta-adrenergic receptors in the cerebral cortex. Adv Cyclic Nucleotide Res. 1978; 9:465-83.
    View in: PubMed
    Score: 0.005
  76. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol Pharmacol. 1977 Nov; 13(6):1170-80.
    View in: PubMed
    Score: 0.005
  77. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex. J Pharmacol Exp Ther. 1977 Oct; 203(1):132-43.
    View in: PubMed
    Score: 0.005
  78. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme. J Pharmacol Exp Ther. 1977 Sep; 202(3):590-600.
    View in: PubMed
    Score: 0.005
  79. Ontogeny of beta-adrenergic receptors in rat cerebral cortex. Brain Res. 1977 Apr 08; 125(1):99-108.
    View in: PubMed
    Score: 0.005
  80. Octopamine: normal occurrence in central and peripheral nerves of rats. Psychopharmacol Bull. 1976 Oct; 12(4):32-4.
    View in: PubMed
    Score: 0.005
  81. Differential effects of nerve impulses on adrenergic storage vesicles in rat heart. J Pharmacol Exp Ther. 1976 Jul; 198(1):112-22.
    View in: PubMed
    Score: 0.005
  82. Endogenous inhibitors of dopamine-beta- hydroxylase in rat organs. Biochem Pharmacol. 1976 May 15; 25(10):1167-74.
    View in: PubMed
    Score: 0.005
  83. Distribution and properties of adrenergic storage vesicles in nerve terminals. J Pharmacol Exp Ther. 1976 Feb; 196(2):346-59.
    View in: PubMed
    Score: 0.005
  84. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec; 350(6):611-7.
    View in: PubMed
    Score: 0.004
  85. Proceedings: Dopamine-beta-hydroxylase and the regulation of the noradrenergic neuron. Psychopharmacol Bull. 1974 Jul; 10(3):24-5.
    View in: PubMed
    Score: 0.004
  86. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol. 1994 May; 45(5):846-53.
    View in: PubMed
    Score: 0.004
  87. Induction of dopamine- -hydroxylase and tyrosine hydroxylase in rat hearts and sympathetic ganglia. J Pharmacol Exp Ther. 1972 Jul; 182(1):116-29.
    View in: PubMed
    Score: 0.004
  88. Distribution and turnover of octopamine in tissues. J Neurochem. 1972 Jan; 19(1):157-63.
    View in: PubMed
    Score: 0.003
  89. Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity. J Neurochem. 1972 Jan; 19(1):195-204.
    View in: PubMed
    Score: 0.003
  90. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. Anat Rec. 1991 Dec; 231(4):548-58.
    View in: PubMed
    Score: 0.003
  91. Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine- -hydroxylase in sympathetic ganglia of the rat. J Pharmacol Exp Ther. 1971 Sep; 178(3):417-24.
    View in: PubMed
    Score: 0.003
  92. A sensitive enzymatic assay for dopamine- -hydroxylase. J Pharmacol Exp Ther. 1971 Sep; 178(3):425-31.
    View in: PubMed
    Score: 0.003
  93. Trans-synaptic induction of dopamine (3,4-dihydroxyphenethylamine) -hydroxylase in adrenergic tissues of the rat. Biochem J. 1971 Jul; 123(4):32P-33P.
    View in: PubMed
    Score: 0.003
  94. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 1991 Jun 21; 60(2):161-77.
    View in: PubMed
    Score: 0.003
  95. Biochemistry of catecholamines. Annu Rev Biochem. 1971; 40:465-500.
    View in: PubMed
    Score: 0.003
  96. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A. 1970 Jun; 66(2):453-8.
    View in: PubMed
    Score: 0.003
  97. An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines. J Pharmacol Exp Ther. 1969 Dec; 170(2):253-61.
    View in: PubMed
    Score: 0.003
  98. Octopamine: normal occurrence in sympathetic nerves of rats. Science. 1969 Apr 25; 164(3878):428-9.
    View in: PubMed
    Score: 0.003
  99. Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor. J Neurochem. 1988 Aug; 51(2):391-7.
    View in: PubMed
    Score: 0.003
  100. Effects of isoproterenol on the development of beta-adrenergic receptors in brain cell aggregates. Brain Res. 1981 Feb 23; 207(1):174-7.
    View in: PubMed
    Score: 0.002
  101. Effect of central catecholamine depletion on the osmotic and nonosmotic stimulation of vasopressin (antidiuretic hormone) in the rat. J Clin Invest. 1979 Dec; 64(6):1599-607.
    View in: PubMed
    Score: 0.001
  102. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. J Pharmacol Exp Ther. 1977 Sep; 202(3):544-57.
    View in: PubMed
    Score: 0.001
  103. Induction of dopamine- -hydroxylase in rat superior cervical ganglia in organ culture. J Neurochem. 1972 Mar; 19(3):919-21.
    View in: PubMed
    Score: 0.001
  104. Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. Mol Pharmacol. 1972 Jan; 8(1):50-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.